Unlocking continuous, real-time health monitoring through advanced transdermal sensor technology.
For over a decade, Zimmer and Peacock (ZP) has been at the forefront of a quiet revolution in biosensing. From sensors implanted in laboratory animals to wearable devices, our journey has been focused on one goal: making reliable, continuous health monitoring a seamless part of everyday life.
Today, we’re excited to share an update on one of our most promising technologies: wearable microneedle biosensors. This technology, protected by a suite of 50 patents, represents a significant leap forward for applications like Continuous Glucose Monitoring (CGM) and beyond.
From Implantable to Wearable: The Evolution of Biosensors
Our expertise is rooted in electrochemical sensing. Over the years, we've developed biosensors for a wide range of environments:
Implantable Sensors: Our early work involved sensors designed for medium to long-term implantation. For instance, we've successfully deployed glucose sensors in animal models, such as fish and pigs, providing valuable data for research and development. These projects demonstrated the robustness and reliability of our sensing technology.
Transdermal (On-Skin) Sensors: A major area of our focus is transdermal sensing—technology that works that travers into the interstial fluid (ISF).
Microneedle technology offers a compelling next step.
Microneedles are tiny, painless structures that penetrate the outermost layer of the skin to access interstitial fluid with minimal invasiveness.
A Live System: Patented Technology in Action
Our development in this area isn't just theoretical. For the past seven years, we have been refining a complete, integrated microneedle biosensor system. This system includes:
The Microneedle Array: The core of the technology, designed for effective and comfortable ISF testing.
Seamless Connectivity: Integrated Bluetooth that streams data directly to a smartphone application.
Cloud Data Platform: The data is securely sent to our cloud platform, Djuli, enabling remote monitoring, data analytics, and long-term trend analysis.
This end-to-end solution demonstrates that the technology is not just a prototype but a viable platform ready for commercial development.
Partnering for the Future: Our Contract Development Model
At ZP, our business model is built on partnership. We are a contract development and manufacturing organization (CDMO). For well-funded companies with a strong business plan, we offer:
Access to Patented Technology: We license our extensive IP portfolio to accelerate your time to market.
End-to-End Expertise: From initial concept and development to scalable manufacturing, we provide comprehensive support.
A Proven Track Record: Our decade of experience in electrochemistry and biosensor design de-risks the development process for our partners.
Summary: The Next Step in Wearable Biosensors
The field of wearable biosensors is evolving rapidly, driven by growing global health needs. ZP is positioned to help innovators lead this change.
In summary:
Proven Expertise: Over a decade of experience in implantable, on-skin, and microneedle biosensors.
Mature Technology: A patented microneedle platform refined over seven years of development.
Complete Solution: A fully integrated system with hardware, software, and cloud connectivity.
Partnership Ready: We are seeking partners to bring this transformative technology to market.
Are You Developing the Next Generation of Wearable Biosensors?
If your company is working on a cutting-edge health monitoring application and you need a proven, IP-protected technology partner, let's talk. Our microneedle platform could be the perfect foundation for your product.
